According to published studies [5,6], up to 15% of patients with COVID-19 had elevated high-sensitive cardiac troponin I (hs-cTnI) during hospitalisation, an indication of myocardial injury, and cardiac involvement in severe-type patients was up to 31%. The gene discussed is TNNI3; the disease is COVID-19.